132 related articles for article (PubMed ID: 1702211)
21. Expression of CD64 (FcγRI) in skin of patients with acute GVHD.
van Royen-Kerkhof A; Walraven V; Sanders EA; de Weger R; van Wichen DF; de Koning E; Thepen T; van de Winkel JG; Leusen JH
Bone Marrow Transplant; 2011 Dec; 46(12):1566-9. PubMed ID: 21243031
[TBL] [Abstract][Full Text] [Related]
22. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
23. Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response.
Fondi C; Nozzoli C; Benemei S; Baroni G; Saccardi R; Guidi S; Nicoletti P; Bartolozzi B; Pimpinelli N; Santucci M; Bosi A; Massi D
Biol Blood Marrow Transplant; 2009 Aug; 15(8):938-47. PubMed ID: 19589483
[TBL] [Abstract][Full Text] [Related]
24. Graft-versus-host disease after marrow transplantation.
Storb R
Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
[TBL] [Abstract][Full Text] [Related]
25. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.
Taylor AL; Gibbs P; Sudhindran S; Key T; Goodman RS; Morgan CH; Watson CJ; Delriviere L; Alexander GJ; Jamieson NV; Bradley JA; Taylor CJ
Transplantation; 2004 Feb; 77(3):441-6. PubMed ID: 14966423
[TBL] [Abstract][Full Text] [Related]
26. Measurement of recipient-specific alloreactivity: is GVHD predictable?
Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
[TBL] [Abstract][Full Text] [Related]
27. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
Kohler PC; Erickson C; Finlay JL; Trigg ME; Edwards B; Hong R; Hank JA; Billing R; Bozdech M; Sondel PM
Cancer Res; 1986 Oct; 46(10):5413-8. PubMed ID: 3530439
[TBL] [Abstract][Full Text] [Related]
28. Treatment of steroid-resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies.
Hebart H; Ehninger G; Schmidt H; Berner B; Reuss-Borst M; Waller HD; Müller CA; Einsele H
Bone Marrow Transplant; 1995 Jun; 15(6):891-4. PubMed ID: 7581087
[TBL] [Abstract][Full Text] [Related]
29. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
[TBL] [Abstract][Full Text] [Related]
30. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis.
Firoz BF; Lee SJ; Nghiem P; Qureshi AA
Arch Dermatol; 2006 Feb; 142(2):175-82. PubMed ID: 16490845
[TBL] [Abstract][Full Text] [Related]
31. Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD.
Puppo F; Brenci S; Ghio M; Bignardi D; Contini P; Bacigalupo A; Van Lint MT; Scudeletti M; Ferrone S; Indiveri F
Bone Marrow Transplant; 1996 May; 17(5):753-8. PubMed ID: 8733693
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow.
Sakamoto K; Sachs DH; Shimada S; Popitz-Bergez FA; Pennington LR; Pescovitz MD; McDonough MA; MacVittie TJ; Katz SI; Gress RE
Transplantation; 1988 May; 45(5):869-75. PubMed ID: 3285532
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous immunological studies in diagnosis of acute graft-versus-host disease.
Dreno B; Milpied N; Harousseau JL; Stalder JF; Bureau B; Milpied B; Barriere H
Br J Dermatol; 1986 Jan; 114(1):7-15. PubMed ID: 3510654
[TBL] [Abstract][Full Text] [Related]
34. Epithelial class II antigen expression in cutaneous graft-versus-host disease.
Beschorner WE; Farmer ER; Saral R; Stirling WL; Santos GW
Transplantation; 1987 Aug; 44(2):237-43. PubMed ID: 3307048
[TBL] [Abstract][Full Text] [Related]
35. Atopic dermatitis-like presentation of graft-versus-host disease: a novel form of chronic cutaneous graft-versus-host disease.
Wei J; Zhang Y; Xu H; Jin J; Zhang J
J Am Acad Dermatol; 2013 Jul; 69(1):34-9. PubMed ID: 23375455
[TBL] [Abstract][Full Text] [Related]
36. The histological diagnosis of cutaneous graft versus host disease: relationship of skin changes to marrow purging and other clinical variables.
Elliott CJ; Sloane JP; Sanderson KV; Vincent M; Shepherd V; Powles R
Histopathology; 1987 Feb; 11(2):145-55. PubMed ID: 3552928
[TBL] [Abstract][Full Text] [Related]
37. [Histopathological findings and biomarker analysis in cutaneous graft-versus-host disease ].
García Gutiérrez JV; González García C; Fleta B; Sánchez-Ortega I; Herrera P; Chinea A; López J; Ramos L; Ramos RP; Duarte R; Odriozola J
Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():19-23. PubMed ID: 21381284
[TBL] [Abstract][Full Text] [Related]
38. Histopathological diagnosis of graft-versus-host disease of the skin: an interobserver comparison.
Ziemer M; Haeusermann P; Janin A; Massi D; Ziepert M; Wolff D; Greinix H; Hillen U
J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):915-24. PubMed ID: 23906476
[TBL] [Abstract][Full Text] [Related]
39. A prospective study of the histological changes in the skin in patients receiving bone marrow transplants.
Lever R; Turbitt M; Mackie R; Hann I; Gibson B; Burnett A; Willoughby M
Br J Dermatol; 1986 Feb; 114(2):161-70. PubMed ID: 2936371
[TBL] [Abstract][Full Text] [Related]
40. Extra-domain-A fibronectin: a new marker of fibrosis in cutaneous graft-versus-host disease.
van der Straaten HM; Canninga-van Dijk MR; Verdonck LF; Castigliego D; Borst HP; Aten J; Fijnheer R
J Invest Dermatol; 2004 Dec; 123(6):1057-62. PubMed ID: 15610514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
